{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:07:06Z","timestamp":1789031226867,"version":"build-2803163510"},"reference-count":37,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS","doi-asserted-by":"publisher","award":["JP23K14660"],"award-info":[{"award-number":["JP23K14660"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"award":["JP23K14660"],"award-info":[{"award-number":["JP23K14660"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background: Although intracellular delivery via endocytosis is a promising strategy for drugs acting in the cytosol or nucleus, many macromolecular therapeutics remain trapped within endosomal\/lysosomal compartments, limiting efficient cytosolic delivery. In this study, we designed a novel functional hyaluronic acid (HA)-based polymer, HA\u2013octahistidine (His8), by conjugating His8 to CD44-targeting HA, and evaluated its physicochemical properties, cellular uptake, and endosomal escape capability. Methods: HA\u2013His8 was synthesized via 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide\/N-hydroxysuccinimide (EDC\/NHS)-mediated coupling and characterized using 1H NMR spectroscopy. Particle size and zeta potential were measured via dynamic light scattering, and buffering capacity was evaluated using acid\u2013base titration. Cellular uptake and intracellular localization were investigated in CD44-high MDA-MB-231 and CD44-low MCF-7 cells via confocal laser scanning microscopy. Cytotoxicity was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Results: Successful conjugation of His8 was confirmed with a degree of substitution of 4.66 mol% relative to HA carboxyl groups. HA\u2013His8 exhibited a nanoscale hydrodynamic diameter under physiological conditions, which increased under acidic conditions together with changes in zeta potential. HA\u2013His8 exhibited higher buffering capacity than free His8 and was preferentially internalized by CD44-high MDA-MB-231 cells compared with MCF-7 cells. Compared with unmodified HA, HA\u2013His8 exhibited lower colocalization with LysoTracker that decreased over time, indicating reduced retention within acidic vesicles. HA\u2013His8 also exhibited low cytotoxicity over the tested concentration range. Conclusions: His8 modification alters HA intracellular localization while preserving CD44 targeting, thereby facilitating endosomal escape. These findings highlight HA\u2013His8 as a potential platform for the cytosolic delivery of macromolecular therapeutics, including proteins, peptides, and nucleic acids.<\/jats:p>","DOI":"10.3390\/pharmaceutics18091137","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:07:41Z","timestamp":1789027661000},"page":"1137","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Histidine\u2013Octamer-Modified Hyaluronic Acid as a Cytosolic Drug Delivery Material via CD44-Mediated Cellular Uptake and Endosomal Escape"],"prefix":"10.3390","volume":"18","author":[{"given":"Tomona","family":"Yukimura","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama 350-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Hirono","family":"Ito","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama 350-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"validation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4443-5340","authenticated-orcid":false,"given":"Takahiro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Saitama Medical University Hospital, Saitama 350-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Toshinobu","family":"Seki","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama 350-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"given":"Tomohiro","family":"Seki","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama 350-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/s41587-022-01582-x","article-title":"Biopharmaceutical Benchmarks 2022","volume":"40","author":"Walsh","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-pharmtox-061724-080811","article-title":"How Biologics Have Changed the Drug Discovery Landscape","volume":"65","author":"McGonigle","year":"2025","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"105664","DOI":"10.1016\/j.jddst.2024.105664","article-title":"Recent Progress in Macromolecules: From Current Therapeutic Strategies to Theranostic Applications","volume":"96","author":"Kumar","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev-chembioeng-100522-102155","article-title":"Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment","volume":"15","author":"Fine","year":"2024","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e202400274","DOI":"10.1002\/cmdc.202400274","article-title":"Enhancing Targeted Drug Delivery through Cell-Specific Endosomal Escape","volume":"19","author":"Chen","year":"2024","journal-title":"ChemMedChem"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"15465","DOI":"10.1039\/D4NR02093F","article-title":"Intracellular Delivery Strategies Using Membrane-Interacting Peptides and Proteins","volume":"16","author":"Mai","year":"2024","journal-title":"Nanoscale"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"102501","DOI":"10.1016\/j.cbpa.2024.102501","article-title":"Recent Advances in Methods for Quantifying the Cell Penetration of Macromolecules","volume":"81","author":"Batistatou","year":"2024","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2019.08.004","article-title":"Brief Update on Endocytosis of Nanomedicines","volume":"144","author":"Patel","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.2147\/IJN.S274289","article-title":"Endocytosis and Organelle Targeting of Nanomedicines in Cancer Therapy","volume":"15","author":"Wang","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/acsnano.5c18112","article-title":"The Biology of Endosomal Escape: Strategies for Enhanced Delivery of Therapeutics","volume":"20","author":"Chahal","year":"2026","journal-title":"ACS Nano"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1039\/D5PM00129C","article-title":"Breaking the Cellular Delivery Bottleneck: Recent Developments in Direct Cytosolic Delivery of Biologics","volume":"2","author":"Nagaraj","year":"2025","journal-title":"RSC Pharm."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","article-title":"Endosomal Escape Pathways for Delivery of Biologicals","volume":"151","author":"Varkouhi","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/bip.21487","article-title":"Endosome-disruptive Peptides for Improving Cytosolic Delivery of Bioactive Macromolecules","volume":"94","author":"Nakase","year":"2010","journal-title":"Pept. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wang, S. (2021). pH-Responsive Amphiphilic Carboxylate Polymers: Design and Potential for Endosomal Escape. Front. Chem., 9.","DOI":"10.3389\/fchem.2021.645297"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e3466","DOI":"10.1002\/psc.3466","article-title":"Artificial Peptides to Induce Membrane Denaturation and Disruption and Modulate Membrane Composition and Fusion","volume":"29","author":"Cotroneo","year":"2023","journal-title":"J. Pept. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1475-2859-10-101","article-title":"Biological Activities of Histidine-Rich Peptides; Merging Biotechnology and Nanomedicine","volume":"10","author":"Corchero","year":"2011","journal-title":"Microb. Cell Factories"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/nar\/28.2.504","article-title":"Histidylated Oligolysines Increase the Transmembrane Passage and the Biological Activity of Antisense Oligonucleotides","volume":"28","author":"Pichon","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/(SICI)1097-0290(20000120)67:2<217::AID-BIT11>3.0.CO;2-Q","article-title":"Design of Imidazole-Containing Endosomolytic Biopolymers for Gene Delivery","volume":"67","author":"Pack","year":"2000","journal-title":"Biotechnol. Bioeng."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/j.actbio.2009.04.021","article-title":"Improving Chitosan-Mediated Gene Transfer by the Introduction of Intracellular Buffering Moieties into the Chitosan Backbone","volume":"5","author":"Moreira","year":"2009","journal-title":"Acta Biomater."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"He, J., Xu, S., and Mixson, A.J. (2020). The Multifaceted Histidine-Based Carriers for Nucleic Acid Delivery: Advances and Challenges. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12080774"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"127157","DOI":"10.1016\/j.ijpharm.2026.127157","article-title":"Dual-Trigger Hyaluronic Acid Nanoprodrug Incorporating a 2-Nitrobenzenesulfonyl Linker for CD44-Targeted and Glutathione-Responsive Drug Delivery","volume":"701","author":"Yukimura","year":"2026","journal-title":"Int. J. Pharm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1080\/10717544.2018.1450910","article-title":"Application of Hyaluronic Acid as Carriers in Drug Delivery","volume":"25","author":"Huang","year":"2018","journal-title":"Drug Deliv."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejpb.2015.03.032","article-title":"Hyaluronic Acid and Its Derivatives in Drug Delivery and Imaging: Recent Advances and Challenges","volume":"97","author":"Tripodo","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1158\/1078-0432.CCR-09-0479","article-title":"Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities","volume":"15","author":"Toole","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1039\/b900456d","article-title":"Self-Assembled Hyaluronic Acid Nanoparticles as a Potential Drug Carrier for Cancer Therapy: Synthesis, Characterization, and In Vivo Biodistribution","volume":"19","author":"Choi","year":"2009","journal-title":"J. Mater. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2011.04.007","article-title":"Hyaluronic Acid-Based Clinical Biomaterials Derived for Cell and Molecule Delivery in Regenerative Medicine","volume":"155","author":"Prestwich","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Fu, C.-P., Cai, X.-Y., Chen, S.-L., Yu, H.-W., Fang, Y., Feng, X.-C., Zhang, L.-M., and Li, C.-Y. (2023). Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery. Polymers, 15.","DOI":"10.3390\/polym15102317"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"43550","DOI":"10.1074\/jbc.M308199200","article-title":"Hyaluronan Recognition Mode of CD44 Revealed by Cross-Saturation and Chemical Shift Perturbation Experiments","volume":"278","author":"Takeda","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"119451","DOI":"10.1016\/j.biomaterials.2019.119451","article-title":"Influence of Hyaluronic Acid Modification on CD44 Binding towards the Design of Hydrogel Biomaterials","volume":"222","author":"Kwon","year":"2019","journal-title":"Biomaterials"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.colsurfb.2011.10.029","article-title":"Hyaluronic Acid-Based Nanocarriers for Intracellular Targeting: Interfacial Interactions with Proteins in Cancer","volume":"99","author":"Choi","year":"2012","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11095-026-04014-6","article-title":"Potential Enhancement of Topical Drug Delivery Using Grapefruit-Derived Nanoparticles Modified Using TAT Peptide","volume":"43","author":"Kanai","year":"2026","journal-title":"Pharm. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jconrel.2009.11.023","article-title":"Hybrid Hyaluronan Hydrogel Encapsulating Nanogel as a Protein Nanocarrier: New System for Sustained Delivery of Protein with a Chaperone-like Function","volume":"142","author":"Hirakura","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.carbpol.2014.02.070","article-title":"A Systematic Analysis of DMTMM vs EDC\/NHS for Ligation of Amines to Hyaluronan in Water","volume":"108","author":"Eglin","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"133063","DOI":"10.1016\/j.ijbiomac.2024.133063","article-title":"Hyaluronic Acid Nanoparticles for Targeted Oral Delivery of Doxorubicin: Lymphatic Transport and CD44 Engagement","volume":"273","author":"Wu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"12653","DOI":"10.1039\/D5RA01275A","article-title":"Hyaluronic Acid-Coated Capecitabine Nanostructures for CD44 Receptor-Mediated Targeting in Breast Cancer Therapy","volume":"15","author":"Mugundhan","year":"2025","journal-title":"RSC Adv."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Henao, M.C., Ocasion, C., Puentes, P.R., Gonz\u00e1lez-Melo, C., Quezada, V., Cifuentes, J., Yepes, A., Burgos, J.C., Cruz, J.C., and Reyes, L.H. (2022). Translocating Peptides of Biomedical Interest Obtained from the Spike (S) Glycoprotein of the SARS-CoV-2. Membranes, 12.","DOI":"10.3390\/membranes12060600"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Torres-Vanegas, J.D., Cifuentes, J., Puentes, P.R., Quezada, V., Garcia-Brand, A.J., Cruz, J.C., and Reyes, L.H. (2022). Assessing Cellular Internalization and Endosomal Escape Abilities of Novel BUFII-Graphene Oxide Nanobioconjugates. Front. Chem., 10.","DOI":"10.3389\/fchem.2022.974218"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/9\/1137\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:14:17Z","timestamp":1789028057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/9\/1137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["pharmaceutics18091137"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18091137","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}